Issue 5/2013
Content (19 Articles)
Chemotherapy plus radiotherapy versus radiotherapy alone in patients with anaplastic glioma: a systematic review and meta-analysis
Lei Zhang, Xiaojun Wu, Tao Xu, Chun Luo, Jun Qian, Yicheng Lu
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies
Nadège Kindt, Julie Preillon, Herbert Kaltner, Hans-Joachim Gabius, Dominique Chevalier, Alexandra Rodriguez, Bryon D. Johnson, Véronique Megalizzi, Christine Decaestecker, Guy Laurent, Sven Saussez
Vimentin as a poor prognostic factor for triple-negative breast cancer
Nami Yamashita, Eriko Tokunaga, Hiroyuki Kitao, Yuichi Hisamatsu, Kenji Taketani, Sayuri Akiyoshi, Satoko Okada, Shinichi Aishima, Masaru Morita, Yoshihiko Maehara
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer
Dina Schütze, Karin Milde-Langosch, Isabell Witzel, Achim Rody, Thomas Karn, Marcus Schmidt, Matthias Choschzick, Fritz Jänicke, Volkmar Müller
Detection of circulating tumor cells in different stages of prostate cancer
Mark Thalgott, Brigitte Rack, Tobias Maurer, Michael Souvatzoglou, Matthias Eiber, Veronika Kreß, Matthias M. Heck, Ulrich Andergassen, Roman Nawroth, Jürgen E. Gschwend, Margitta Retz
TNF-β +252 A>G polymorphism and susceptibility to cancer
Lin Yang, Rennan Feng, Guiyou Liu, Mingzhi Liao, Liangcai Zhang, Wenbo Wang
Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection
Xiaohong Chen, Boheng Zhang, Xin Yin, Zhenggang Ren, Shuangjian Qiu, Jian Zhou
Short-term versus long-term hormone therapy plus radiotherapy or prostatectomy for prostate cancer: a systematic review and meta-analysis
Zhi-Rui Zhou, Xiao-Dong Zhu, Jun Xia, Zhang-Yu Zou, Song Qu, Xian-Tao Zeng, Zhi Mao, Zhong-Guo Liang
Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer
Binglan Zhang, Xuelei Ma, Zhimian Li, Xiang Gao, Fengtian Wang, Lei Liu, Guobo Shen, Yaxiong Sang, Minmin Li, Yuli Li, Jingyi Zhao, Yuquan Wei
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers
Isabell Witzel, Monika Graeser, Thomas Karn, Markus Schmidt, Ralph Wirtz, Dina Schütze, Alma Rausch, Fritz Jänicke, Karin Milde-Langosch, Volkmar Müller
Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component
Inkeun Park, Yong Mee Cho, Jae-Lyun Lee, Jin-Hee Ahn, Dae-Ho Lee, Cheryn Song, Jun-Hyuk Hong, Choung-Soo Kim, Hanjong Ahn
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)
Umut Demirci, Gulnihal Tufan, Bilge Aktas, Ozan Balakan, Ahmet Alacacioglu, Faysal Dane, Huseyin Engin, M. Ali Kaplan, Yusuf Gunaydin, Nuriye Y. Ozdemir, I. Tugba Unek, Halit Karaca, Tulay Akman, Ozlem U. Sonmez, Ugur Coskun, Hakan Harputluoglu, Alper Sevinc, Onder Tonyali, Suleyman Buyukberber, Mustafa Benekli
Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer
Lisa Gallicchio, Ryan MacDonald, Kathy J. Helzlsouer
Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test
Yusuke Suzuki, Kenji Imai, Koji Takai, Tatsunori Hanai, Hideki Hayashi, Takafumi Naiki, Yoichi Nishigaki, Eiichi Tomita, Masahito Shimizu, Hisataka Moriwaki
Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis
T. Gamucci, A. Vaccaro, F. Ciancola, L. Pizzuti, I. Sperduti, L. Moscetti, F. Longo, M. A. Fabbri, M. A. Giampaolo, L. Mentuccia, L. Di Lauro, P. Vici
Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy
Koji Teramoto, Yasuhiko Ohshio, Takuya Fujita, Jun Hanaoka, Keiichi Kontani
Laparoscopic radical prostatectomy plus extended lymph nodes dissection for cases with non-extra node metastatic prostate cancer: 5-year experience in a single Chinese institution
Ming-Kun Chen, Yun Luo, Hao Zhang, Jiang-Guang Qiu, Xin-Qiao Wen, Jun Pang, Jie Si-Tu, Qi-Peng Sun, Xin Gao
Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer
Kiyoshi Misawa, Takeharu Kanazawa, Yuki Misawa, Atsushi Imai, Takayuki Uehara, Daiki Mochizuki, Shiori Endo, Goro Takahashi, Hiroyuki Mineta
PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis
Shuangjie Wu, Yu Gan, Xinhai Wang, Jun Liu, Mengjun Li, Yifan Tang